WST · CIK 0000105770 · operating
Founded in 1923 and headquartered in Exton, Pennsylvania, West Pharmaceutical Services designs and manufactures containment and delivery systems for injectable drugs and healthcare products. The company produces stoppers, seals, syringe components, and cartridges used in pharmaceutical packaging, along with self-injection devices and films or coatings that enhance product quality. Its offerings also include reconstitution and transfer technologies for drug administration, analytical lab services, and regulatory support for pharmaceutical and biologic manufacturers.
The company operates through two primary segments. Its Proprietary Products division develops and manufactures specialized packaging components and integrated delivery solutions serving biologic, generic, and pharmaceutical companies. The Contract-Manufactured Products segment designs and assembles devices for use in surgical, diagnostic, ophthalmic, injectable, and other drug delivery applications, serving pharmaceutical, diagnostic, and medical device manufacturers.
West Pharmaceutical operates across the Americas, Europe, the Middle East, Africa, and Asia Pacific through a direct sales force, distribution networks, contract sales agents, and regional distributors. The company employs approximately 10,800 full-time employees and maintains a market capitalization of $18.3 billion as of the latest available data.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $6.79 | $6.83 | +1.5% | |
| 2024 | $6.69 | $6.75 | -15.1% | |
| 2023 | $7.88 | $7.98 | +1.9% | |
| 2022 | $7.73 | $7.87 | -10.8% | |
| 2021 | $8.67 | $8.89 | +572.1% | |
| 2020 | $1.29 | $1.32 | -59.8% | |
| 2019 | $3.21 | $3.27 | +17.2% | |
| 2018 | $2.74 | $2.80 | +37.7% | |
| 2017 | $1.99 | $2.04 | +4.2% | |
| 2016 | $1.91 | $1.96 | +46.9% | |
| 2015 | $1.30 | $1.33 | -25.7% | |
| 2014 | $1.75 | $1.79 | +11.5% | |
| 2013 | $1.57 | $1.61 | -31.7% | |
| 2012 | $2.30 | $2.37 | +21.7% | |
| 2010 | $1.89 | $1.96 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-17 | 0000105770-26-000010 | SEC ↗ |
| 2024-12-31 | 2025-02-18 | 0000105770-25-000013 | SEC ↗ |
| 2023-12-31 | 2024-02-20 | 0000105770-24-000015 | SEC ↗ |
| 2022-12-31 | 2023-02-21 | 0000105770-23-000012 | SEC ↗ |
| 2021-12-31 | 2022-02-22 | 0001628280-22-003342 | SEC ↗ |
| 2020-12-31 | 2021-02-23 | 0000105770-21-000008 | SEC ↗ |
| 2019-12-31 | 2020-02-24 | 0000105770-20-000015 | SEC ↗ |
| 2018-12-31 | 2019-02-28 | 0000105770-19-000012 | SEC ↗ |
| 2017-12-31 | 2018-02-26 | 0000105770-18-000006 | SEC ↗ |
| 2016-12-31 | 2017-02-28 | 0000105770-17-000011 | SEC ↗ |
| 2015-12-31 | 2016-02-26 | 0000105770-16-000060 | SEC ↗ |
| 2014-12-31 | 2015-02-25 | 0000105770-15-000007 | SEC ↗ |